Article Details
Retrieved on: 2021-02-25 15:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Perhaps the anti-GM-CSF mechanism can echo the recent success of Roche's anti-IL-6 MAb Actemra, which acts on a different inflammatory pathway ...
Article found on: www.evaluate.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here